Welcome

Dear Colleagues,

Dystonias are amongst the most common movement disorders. Botulinum toxin therapy and deep brain stimulation have revolutionized their therapy. However, there are considerable unmet therapeutical needs. With this meeting we want to advance existent therapies, improve their differential use and stimulate research in new therapeutic approaches.

We hope that this meeting will serve as an open platform for all who take care of people with dystonia.

Eckart Altenmüller		Dirk Dressler		Joachim K. Krauss